From the Department of Anaesthesiology and Intensive Care Medicine, University Hospital of Cologne, Cologne, Germany (JH), Anaesthesiology Institute, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates (ML), Department of Clinical Sciences Malmö, Anaesthesiology and Intensive Care Medicine, Lund University Faculty of Medicine, Malmö, Sweden (JA), Centre for Evidence-Based Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal (JS,JC), Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples 'Federico II', Naples, Italy (EDR), Department of Anaesthesiology and Intensive Care, Hôpitaux Universitaires Paris Nord Val de Sein, Paris, France (DL), Clinical Department of Anaesthesiology and Intensive Care, University Medical Centre, Ljubljana, Slovenia (VNJ), Perioperative Medicine, Pain Therapy, RRS and Intensive Care Department, Anaesthesiology and Intensive Care University of Chieti-Pescara, Chieti, Italy (FP), Department of Anaesthesiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands (MMRFS), Anesthésie, Hôpital Jeanne de Flandre, Lille (FV), Fuchs-Buder T. Department of Anaesthesiology and Critical Carel, CHRU Nancy, University of Lorraine, Nancy, France (TFB); and Karl Landsteiner Institute for Anaesthesiology and Intensive Care Medicine, Vienna, Austria (RF) *Chairman of the ESA/EBA taskforce for procedural sedation and analgesia guidelines in adults. †Co-chairman of the ESA/EBA taskforce for procedural sedation and analgesia guidelines in adults.
Chairman of the ESA/EBA taskforce for procedural sedation and analgesia guidelines in adults.
Eur J Anaesthesiol. 2018 Jan;35(1):6-24. doi: 10.1097/EJA.0000000000000683.
: Procedural sedation and analgesia (PSA) has become a widespread practice given the increasing demand to relieve anxiety, discomfort and pain during invasive diagnostic and therapeutic procedures. The role of, and credentialing required by, anaesthesiologists and practitioners performing PSA has been debated for years in different guidelines. For this reason, the European Society of Anaesthesiology (ESA) and the European Board of Anaesthesiology have created a taskforce of experts that has been assigned to create an evidence-based guideline and, whenever the evidence was weak, a consensus amongst experts on: the evaluation of adult patients undergoing PSA, the role and competences required for the clinicians to safely perform PSA, the commonly used drugs for PSA, the adverse events that PSA can lead to, the minimum monitoring requirements and post-procedure discharge criteria. A search of the literature from 2003 to 2016 was performed by a professional librarian and the retrieved articles were analysed to allow a critical appraisal according to the Grading of Recommendations Assessment, Development and Evaluation method. The Taskforce selected 2248 articles. Where there was insufficiently clear and concordant evidence on a topic, the Rand Appropriateness Method with three rounds of Delphi voting was used to obtain the highest level of consensus among the taskforce experts.These guidelines contain recommendations on PSA in the adult population. It does not address sedation performed in the ICU or in children and it does not aim to provide a legal statement on how PSA should be performed and by whom. The National Societies of Anaesthesiology and Ministries of Health should use this evidence-based document to help decision-making on how PSA should be performed in their countries. The final draft of the document was available to ESA members via the website for 4 weeks with the facility for them to upload their comments. Comments and suggestions of individual members and national Societies were considered and the guidelines were amended accordingly. The ESA guidelines Committee and ESA board finally approved and ratified it before publication.
: 程序性镇静和镇痛 (PSA) 已广泛应用于缓解侵入性诊断和治疗过程中的焦虑、不适和疼痛。多年来,不同的指南一直在争论麻醉师和进行 PSA 的从业者的作用和所需的认证。出于这个原因,欧洲麻醉学会 (ESA) 和欧洲麻醉委员会成立了一个专家工作组,负责制定一个基于证据的指南,以及在证据薄弱的情况下,就以下方面达成专家共识:接受 PSA 的成人患者评估、临床医生安全进行 PSA 所需的角色和能力、PSA 常用药物、PSA 可能导致的不良事件、最低监测要求和术后出院标准。专业图书馆员对 2003 年至 2016 年的文献进行了检索,检索到的文章进行了分析,以便根据推荐评估、制定和评估方法进行批判性评价。工作组选择了 2248 篇文章。在某个主题上,如果证据不够明确和一致,则使用 Rand 适宜性方法进行三轮 Delphi 投票,以在工作组专家中获得最高水平的共识。这些指南包含了关于成人 PSA 的建议。它不涉及在 ICU 或儿童中进行的镇静,也不旨在就 PSA 应该如何进行以及应由谁进行提供法律声明。国家麻醉学会和卫生部应使用这份基于证据的文件,帮助就 PSA 在本国的实施方式做出决策。文件的最终草案在网站上向 ESA 成员提供了 4 周的时间,供他们上传评论。个别成员和国家学会的意见和建议都得到了考虑,并对指南进行了相应的修订。ESA 指南委员会和 ESA 董事会最终批准并批准了该指南,然后才发布。